Benchling
PrivateLast Round
Series F
Nov 17, 2021
Est. Valuation
$6.1B
Total Funding Raised
$412.05M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Benchling operates in Enterprise Software and is based in San Francisco, California. Its latest recorded funding round was a Series F round in November 2021.
Benchling is a life sciences company that provides a cloud-based R&D platform for biotech and life sciences companies to design, share, and record experiments.
Sector
Enterprise Software
Verticals
Biotechnology, Drug Discovery, Vertical SaaS, Workflow Automation, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Application
Price History
Caplight MarketPrice™ estimate for Benchling, published with a 90-day delay.
Caplight MarketPrice™
$9.91
per share, as of December 2025
+0.7%
2-year change
The most recent months of MarketPrice™ are available to Caplight clients.
Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.
Benchling Comparables
Compare Benchling with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cenevo | 82% | |
| Sapio Sciences | 82% | |
| Eppendorf SE | 79% |
For institutional investors. Book with your work email.
Benchling Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Nov 17, 2021 | ||||
| Series E | Apr 14, 2021 | ||||
| Series D | May 28, 2020 | ||||
| Series C | Jul 24, 2019 | ||||
| Series B | Jun 14, 2018 | ||||
Series A | Oct 24, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Benchling Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Series C, Series Seed |
| Human Capital | Series F |
| Benchmark Capital | Series E, Series D, Series C, Series B |
| SV Angel | Seed, Series Seed, Accelerator |
| ICONIQ Capital | Series E, Series D |
| F-Prime Capital | Series C, Series B |
| Founders Fund | Seed, Series Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Integrated with Seqera Labs and Amazon S3 for R&D lifecycle management.
- Apr 27, 2026
Integration to expose ClinicalTrials.gov as a trusted scientific data source.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 15, 2026
Benchling, Inc. launches Science Foundries, a platform for scientists and agents to run scientific processes end-to-end together, in California on Oct 15th '26.
- launchesSep 19, 2026
Benchling, Inc. launches its API suite in 2024, reaching approximately 4,000 daily active users at its peak.
- launchesAug 20, 2026
Benchling, Inc. launches Reactions, a capability for planning and modeling single-step synthesis, as part of its chemistry expansion in California on Aug 20th '26.
- integrates_withAug 17, 2026
Benchling, Inc. connects directly with Kyowa Kirin, Inc.'s laboratory instruments in Japan, capturing data automatically as structured, searchable records without manual entry on Aug 16th '26.
For institutional investors. Book with your work email.
Benchling Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Benchling's valuation, stock price, and market status.
Is Benchling a public or private company?
Benchling is a private company.
What is the current stock price of Benchling?
Benchling is a private company, so its shares have no public market price. Caplight tracks Benchling's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Benchling worth (valuation)?
Benchling's valuation is estimated at $6.1B based on funding round data.
Can I buy Benchling stock?
Benchling shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Benchling's last funding round?
Benchling's most recent funding round was Series F on November 17, 2021.
Who are the main investors in Benchling?
Key investors in Benchling include Andreessen Horowitz, Benchmark Capital, Franklin Templeton, Thrive Capital, Alkeon Capital Management.
Will Benchling IPO soon?
No public IPO plans have been announced for Benchling.
How can I track Benchling secondary market activity?
Caplight tracks bids, offers, and trades in Benchling's shares on secondary markets.